Shots:
- Ortho Development has reported the full US commercial launch of the Trivicta Hip Stem, a cementless triple-taper femoral component for primary total hip arthroplasty, following a controlled market introduction
- Trivicta system features a 35μm hydroxyapatite coating over sintered titanium beads to support early osteointegration, alongside standard & extended offset options, progressive neck lengths, & refined distal geometry designed to improve anatomical fit, stability, & surgical versatility
- The platform also incl. a hybrid broach system with anterior & posterior compaction teeth to preserve bone, plus modular instrumentation, & incremental stem sizing aimed at streamlining implant placement & reducing variability
Ref: PRnewswire | Image: Ortho Development | Press Release
Related News: Insulet Enrolls First Patient in the EVOLVE Study of its FCL Omnipod M System for Type 2 Diabetes
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
